Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000342855 | SCV000393833 | uncertain significance | Tay-Sachs disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000342855 | SCV001607800 | likely benign | Tay-Sachs disease | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165854 | SCV003875758 | likely benign | Inborn genetic diseases | 2023-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004546480 | SCV005041512 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | HEXA: BP4, BP7 |
Natera, |
RCV000342855 | SCV001460521 | likely benign | Tay-Sachs disease | 2020-09-16 | no assertion criteria provided | clinical testing |